An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria.
Saved in:
| Title: | An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. |
|---|---|
| Authors: | De A; From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India., Pal S; From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India., Singh S; From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India., Chakroborty D; From the Department of Dermatology, Calcutta National Medical College, Kolkata, West Bengal, India., Godse K; Department of Dermatology, DY Patil University, Navi Mumbai, Maharashtra, India. |
| Source: | Indian journal of dermatology [Indian J Dermatol] 2024 Jul-Aug; Vol. 69 (4), pp. 312-316. Date of Electronic Publication: 2024 Aug 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Medknow Publications Country of Publication: India NLM ID: 0370750 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1998-3611 (Electronic) Linking ISSN: 00195154 NLM ISO Abbreviation: Indian J Dermatol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
